iStock_37438014_XXXLARGE-outlined_LM.png pink_scrubs.png hp-people-3.png man-in-sweater_90824869_v1MAG.png Dr-Glasses.png iStock_86712797_XXXLARGE-outline_LM.png blue_shirt_masthead_man_v1_MAG.png NKT-hp-people-Michelle_v1_LM.png iStock_68713947_XXLARGE-outiline_LM.png NKT-hp-people-Phi_v1_LM.png NKT-hp-people-Mekhala_v1_LM.png hp-people-3.png iStock_87627749_XXXLARGE-outline_LM.png

Events

FEB 15

Analyst Call with Bladder Cancer Specialist at ASCO-GU
San Francisco, CA
2:00 p.m. PT

Webcast Link
Presentation slides

JAN 08

37th Annual J.P. Morgan Healthcare Conference
San Francisco, CA
9:00 a.m. PT

Presentation - 9:00 a.m. PT
Q&A - 9:30 a.m. PT
Presentation slides

NOV 10

Analyst Call with Melanoma Specialists at SITC
Washington, DC
9:00 a.m. EST

Webcast Link

Presentation slides

Leadership Spotlight

Dr. Jonathan Zalevsky, SVP, Biology discusses NKTR-214

Watch

Latest News

OUR PIPELINE

We are focused on using new chemistry approaches to make better medicines to treat cancer, chronic pain and auto-immune disease.

NKTR-214

IMMUNO-ONCOLOGY

PHASE 1/2

  • 9

    9 million patients benefit from our medicines

    9
    9
    9
  • 12

    12 approved products around the world

    12
    12
    12
  • 10

    10 new medicines in development pipeline

    10
    10
    10


Cutting-edge facilities




Dynamic teams




Impactful work


OUR Culture

We are supported by a dynamic team, rich in scientific, business and medical expertise, across three locations.

Read more